FDA Approved Drugs by Medical Condition

Search by medical condition for drugs approved by the Food and Drug Administration (FDA) for sale in the United States. Select the letter below that corresponds to the first letter of the medical condition you are searching for and all approved drugs classified under that category will be listed below.

Waldenstrom Macroglobulinemia

Imbruvica (ibrutinib) (by Pharmacyclics), Approved February 2014
For the treatment of chronic lymphocytic leukemia and Waldenstrom macroglobulinemia

Warts

Aldara (imiquimod) (by 3M Pharmaceuticals), Approved March 1997
Treatment for external genital and perianal warts

Condylox Gel 0.5% (pokofilox) (by Oclassen Pharmaceuticals), Approved March 1997
Treatment for external genital and perianal warts

Veregen (kunecatechins) (by Medigene), Approved October 2006
For the treatment of external genital and perianal warts

Weight Loss

Belviq (lorcaserin hydrochloride) (by Arena Pharmaceuticals), Approved June 2012
For the chronic management of weight loss

Contrave (naltrexone HCl and bupropion HCl) (by Takeda Pharmaceuticals U.S.A.), Approved September 2014
For chronic weight management

Nesina (alogliptin) (by Takeda), Approved January 2013
For the treatment of type II diabetes mellitus

Qsymia (phentermine + topiramate extended-release) (by Vivus), Approved July 2012
For the treatment of chronic weight management

Saxenda (liraglutide [rDNA origin] injection) (by Novo Nordisk), Approved December 2014
For chronic weight management

White Cell Disorders

Sylvant (siltuximab) (by Janssen Biotech), Approved April 2014
For the treatment of multicentric Castleman’s disease

Wilson's Disease

Galzin (zinc acetate) (by Teva Pharmaceutical), Approved January 1997
Treatment for Wilson’s disease

Wounds

Iamin (by ProCyte), Approved February 1996
Gel wound dressing

OsmoCyte Pillow Wound Dressing (by ProCyte), Approved December 1996
Treatment for chronic and acute wounds